The BEYOND⢠study is a phase 3, randomized, double-blind, placebo-controlled study of zigakibart (BION-1301) in adults with IgA nephropathy (IgAN). The BEYOND⢠study is a clinical trial that will test an investigational drug named zigakibart, which is being developed for the treatment of IgAN.
Server
cloudflare
DNS
View domain name system records, including the A, AAAA, MX and NS records.